BioClin has been acquired by Trimb Healthcare
Orange Pearl International has sold BioClin, a leading healthcare products company, to Trimb Healthcare AB, a Swedish pharmaceutical company.
Based in the Netherlands, BioClin sells products to provide direct treatment and relief for women’s intimate health discomforts. The company’s product portfolio consists of Multi-Gyn, a complete range for treating intimate discomforts and Multi-Mam, a product range of self-care products for mothers and babies. BioClin’s brands are growing rapidly and are sold in pharmacies and drugstores in over 60 countries worldwide.
Trimb Healthcare is rapidly growing pharmaceutical company with a focus on sales, marketing and development of prescription-free OTC pharmaceuticals and consumer healthcare products.
Oaklins' team in the Netherlands acted as the exclusive sell-side advisor to the shareholders of BioClin in this transaction.
Talk to the deal team
Casper Oude Essink
Associate Director
Amsterdam, NetherlandsOaklins Netherlands
Related deals
Coastal Insurance Underwriters has been acquired by Constellation Affiliated Partners
The shareholders of Coastal Insurance Underwriters have sold the firm to Constellation Affiliated Partners.
Learn moreBlue Equity is partnering with Bang & Beenfeldt
The private shareholders of Bang & Beenfeldt A/S have sold the company to Blue Equity, with a subsequent reinvestment in the new company.
Learn moreDutch Dental Group has raised new acquisition debt from ING Bank to support its growth strategy
Dutch Dental Group (DDG) has raised a new debt financing package provided by ING Bank, consisting of term loans, an acquisition facility and an RCF.
Learn more